It is evident that treatment for cancer patients and their comorbid depression can improve the quality of life. Although some trials have indicated that psychological and psychiatric treatments improve cancer survival, there is no clinical evidence regarding the effect of treating depression on the survival.
The current study is set out to examine the effect of depression treatment on survival by following up on 642 participants, 500 were included in the SMaRT Oncology-2 trial for good prognosis cancers (estimated ≥12 months survival) and 142 were included in the SMaRT Oncology-3 trial for poor prognosis lung cancer (≥3 months estimated survival) Source: Psychiatry Advisor
